Skip to main content

Surgery for Budd–Chiari Syndrome

  • Chapter
  • First Online:
  • 385 Accesses

Abstract

Budd–Chiari syndrome (BCS) is the disease which represented by an obstruction in the hepatic venous outflow from small hepatic veins to the inferior vena cava (IVC) caused by thrombosis or fibrous sequelae. BCS is a rare disease with an incidence of 0.1 to 10 per million inhabitants a year whose etiological factors include hypercoagulable conditions, myeloprolipherative diseases, anatomical variability of IVC, and environmental conditions. The treatment for BCS contains multi-step management. Initially anticoagulation therapy has tended to be chosen. In patients without any recovery of symptom after anticoagulation therapy, interventional revascularization and the transjugular intrahepatic portosystemic shunt procedure are indicated, whereas IVC plasty with a patch graft and cavo-right atrium, portosystemic shunt is indicated for obstruction of the IVC. The patency of IVC plasty and bypass has been reported as satisfactory. Long-term outcomes after surgical procedures are sustainable but the risk of hepatocellular carcinoma occurrence has been a problem in long-term follow-up. Liver transplantation is usually indicated as a treatment in patients who develop liver failure despite undergoing various treatments.

This is a preview of subscription content, log in via an institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   79.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   99.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   129.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Abbreviations

BCS:

Budd–Chiari syndrome

IVR:

Interventional radiology

PTA:

Percutaneous transluminal angioplasty

TIPS:

Transjugular intrahepatic portosystemic shunt

References

  1. Janssen HL, Garcia-Pagan JC, Elias E, Mentha G, Hadengue A, Valla DC. Budd-Chiari syndrome: a review by an expert panel. J Hepatol. 2003;38:364–71.

    Article  PubMed  Google Scholar 

  2. Budd G. On diseases of the liver. Philadelphia: Lea and Blanchard; 1846.

    Book  Google Scholar 

  3. Chiari H. Ueber die selbstandige Phlebitis obliterans der Hauptstamme der Venae hepaticae als Todesursache. Beitr Pathol Anat Allg Pathol. 1899;26:1–18.

    Google Scholar 

  4. Valla DC. Primary Budd-Chiari syndrome. J Hepatol. 2009;50:195–203.

    Article  PubMed  Google Scholar 

  5. DeLeve LD, Calla DC, Gracia-Tsao G. Vascular disorders of the liver. Hepatology. 2009;49:1729–64.

    Article  CAS  PubMed  Google Scholar 

  6. Okuda H, Yamagata H, Obata H, et al. Epidemiological and clinical features of Budd-Chiari syndrome in Japan. J Hepatol. 1995;22:1–9.

    Article  CAS  PubMed  Google Scholar 

  7. Valla DC. Hepatic venous outflow tract obstruction etiopathogenesis: Asia versus the West. J Gastroenterol Hepatol. 2004;19:S204–11.

    Article  Google Scholar 

  8. Amarapurkar DN, Punamiya SJ, Patel ND. Changing spectrum of Budd-Chiari syndrome in India with special reference to non-surgical treatment. World J Gastroenterol. 2008;14:278–85.

    Article  PubMed  PubMed Central  Google Scholar 

  9. Dilawari JB, Bambery P, Chawla Y, et al. Hepatic outflow obstruction (Budd-Chiari syndrome). Experience with 177 patients and a review of the literature. Medicine (Baltimore). 1994;73:21–36.

    Article  CAS  Google Scholar 

  10. Darwish Murad S, Plessier A, Hernandez-Guerra M, et al. Etiology, management, and outcome of the Budd-Chiari syndrome. Ann Intern Med. 2009;151:167–75.

    Article  PubMed  Google Scholar 

  11. Denninger MH, Chait Y, Casadevall N, et al. Cause of portal or hepatic venous thrombosis in adults: the role of multiple concurrent factors. Hepatology. 2000;31:587–91.

    Article  CAS  PubMed  Google Scholar 

  12. Janssen HL, Meinardi JR, Vleggaar FP, et al. Factor V Leiden mutation, prothrombin gene mutation, and deficiencies in coagulation inhibitors associated with Budd-Chiari syndrome and portal vein thrombosis: results of a case-control study. Blood. 2000;96:2364–8.

    CAS  PubMed  Google Scholar 

  13. Dang X, Li L, Xu P. Research status of Budd-Chiari syndrome in China. Int J Clin Exp Med. 2014;7:4646–52.

    PubMed  PubMed Central  Google Scholar 

  14. Ren W, Li X, Jia J, et al. Prevalence of Budd-Chiari syndrome during pregnancy or Puerperium: a systematic review and meta-analysis. Gastroenterol Res Pract. 2015;2015:839875.

    Article  PubMed  PubMed Central  Google Scholar 

  15. Hadengue A, Poliquin M, Vilgrain V, et al. The changing scene of hepatic vein thrombosis: recognition of asymptomatic cases. Gastroenterology. 1994;106:1042–7.

    Article  CAS  PubMed  Google Scholar 

  16. Sandle GI, Layton M, Record CO, Cowan WK. Fulminant hepatic failure due to Budd Chiari syndrome. Lancet. 1980;1:1199.

    Article  CAS  PubMed  Google Scholar 

  17. Moucari R, Rautou PE, Cazals-Hatem D, et al. Hepatocellular carcinoma in Budd-Chiari syndrome: characteristics and risk factors. Gut. 2008;57:828–35.

    Article  CAS  PubMed  Google Scholar 

  18. Bolondi L, Gaiani S, Li Bassi S, Zironi G, Bonino F, Brunetto M, et al. Diagnosis of Budd-Chiari syndrome by pulsed Doppler ultrasound. Gastroenterology. 1991;100:1324–31.

    Article  CAS  PubMed  Google Scholar 

  19. Zhou P, Ren J, Han X, Wu G, Zhang W, Ding P, et al. Initial imaging analysis of Budd-Chiari syndrome in Henan province of China: most cases have combined inferior vena cava and hepatic veins involvement. PLoS One. 2014;9:e85135.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  20. Plessier A, Valla DC. Budd-Chiari syndrome. Semin Liver Dis. 2008;28:259–69.

    Article  PubMed  Google Scholar 

  21. Orloff MJ, Daily PO, Orloff SL, Girard B, Orloff MS. A 27-year experience with surgical treatment of Budd-Chiari syndrome. Ann Surg. 2000;232:340–52.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  22. Perello A, Garcia-Pagan JC, Gilabert R, Suarez Y, Moitinho E, Cervantes F, et al. TIPS is a useful long-term derivative therapy for patients with Budd–Chiari syndrome uncontrolled by medical therapy. Hepatology. 2002;35:132–9.

    Article  PubMed  Google Scholar 

  23. Zeitoun G, Escolano S, Hadengue A, Azar N, El Younsi M, Mallet A, et al. Outcome of Budd–Chiari syndrome: a multivariate analysis of factors related to survival including surgical portosystemic shunting. Hepatology. 1999;30:84–9.

    Article  CAS  PubMed  Google Scholar 

  24. Langlet P, Escolano S, Valla D, Coste-Zeitoun D, Denie C, Mallet A, et al. Clinicopathological forms and prognostic index in Budd–Chiari syndrome. J Hepatol. 2003;39:496–501.

    Article  PubMed  Google Scholar 

  25. Tang TJ, Batts KP, de Groen PC, van Hoek B, Haagsma EB, Hop WC, et al. The prognostic value of histology in the assessment of patients with Budd–Chiari syndrome. J Hepatol. 2001;35:338–43.

    Article  CAS  PubMed  Google Scholar 

  26. Murad SD, Valla DC, de Groen PC, Zeitoun G, Hopmans JA, Haagsma EB, et al. Determinants of survival and the effect of portosystemic shunting in patients with Budd–Chiari syndrome. Hepatology. 2004;39:500–8.

    Article  Google Scholar 

  27. Seijo S, Plessier A, Hoekstra J, et al. Good long-term outcome of Budd-Chiari syndrome with a step-wise management. Hepatology. 2013;57:1962–8.

    Article  PubMed  Google Scholar 

  28. Plessier A, Sibert A, Consigny Y, et al. Aiming at minimal invasiveness as a therapeutic strategy for Budd-Chiari syndrome. Hepatology. 2006;44:1308–16.

    Article  PubMed  Google Scholar 

  29. Pugh RN, Murray-Lyon IM, Dawson JL, Pietroni MC, Williams R. Transection of the oesophagus for bleeding oesophageal varices. Br J Surg. 1973;60:646–9.

    Article  CAS  PubMed  Google Scholar 

  30. Malinchoc M, Kamath PS, Gordon FD, Peine CJ, Rank J, ter Borg PC. A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts. Hepatology. 2000;31:864–71.

    Article  CAS  PubMed  Google Scholar 

  31. Langlet P, Escolano S, Valla D, et al. Clinicopathological forms and prognostic index in Budd-Chiari syndrome. J Hepatol. 2003;39:496–501.

    Article  PubMed  Google Scholar 

  32. Zeitoun G, Escolano S, Hadengue A, et al. Outcome of Budd-Chiari syndrome: a multivariate analysis of factors related to survival including surgical portosystemic shunting. Hepatology. 1999;30:84–9.

    Article  CAS  PubMed  Google Scholar 

  33. Rautou PE, Moucari R, Escolano S, et al. Prognostic indices for Budd-Chiari syndrome: valid for clinical studies but insufficient for individual management. Am J Gastroenterol. 2009;104:1140–6.

    Article  PubMed  Google Scholar 

  34. Hidaka M, Eguchi S. Budd-Chiari syndrome: focus on surgical treatment. Hepatol Res. 2017;47:142–8.

    Article  PubMed  Google Scholar 

  35. Orloff MJ, Isenberg JI, Wheeler HO, Daily PO, Girard B. Budd-Chiari syndrome revisited: 38 years’ experience with surgical portal decompression. J Gastrointest Surg. 2012;16:286–300.

    Article  PubMed  Google Scholar 

  36. Orloff MJ, Daily PO, Orloff SL, Girard B, Orloff MS. A 27-year experience with surgical treatment of Budd–Chiari syndrome. Ann Surg. 2000;232:340–52.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  37. Orloff MJ, Daily PO, Girard B. Treatment of Budd-Chiari syndrome due to inferior vena cava occlusion by combined portal and vena caval decompression. Am J Surg. 1992;163:137–43.

    Article  CAS  PubMed  Google Scholar 

  38. Bachet JB, Condat B, Hagège H, Plessier A, Consigny Y, Belghiti J, Valla D. Long-term portosystemic shunt patency as a determinant of outcome in Budd-Chiari syndrome. J Hepatol. 2007;46:60–8.

    Article  PubMed  Google Scholar 

  39. Koja K, Kusaba A, Kuniyoshi Y, Iha K, Akasaki M, Miyagi K. Radical open endvenectomy with autologous pericardial patch graft for correction of Budd-Chiari syndrome. Cardiovasc Surg. 1996;4:500–4.

    Article  CAS  PubMed  Google Scholar 

  40. Inafuku H, Morishima Y, Nagano T, Arakaki K, Yamashiro S, Kuniyoshi Y. A three-decade experience of radical open endvenectomy with pericardial patch graft for correction of Budd-Chiari syndrome. J Vasc Surg. 2009;50:590–3.

    Article  PubMed  Google Scholar 

  41. Li Q, Zhang T, Wang D, Li W, Zhang X, Zhang X. Radical surgical treatment of Budd-Chiari syndrome through entire exposure of hepatic inferior vena cava. J Vasc Surg Venous Lymphat Disord. 2019;7:74–81.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Susumu Eguchi .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2020 Springer Nature Singapore Pte Ltd.

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Hidaka, M., Eguchi, S. (2020). Surgery for Budd–Chiari Syndrome. In: Qi, X. (eds) Budd-Chiari Syndrome. Springer, Singapore. https://doi.org/10.1007/978-981-32-9232-1_13

Download citation

  • DOI: https://doi.org/10.1007/978-981-32-9232-1_13

  • Published:

  • Publisher Name: Springer, Singapore

  • Print ISBN: 978-981-32-9231-4

  • Online ISBN: 978-981-32-9232-1

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics